Burning Rock Biotech Ltd
BNR32.660USD
-1.340-3.94%
取引時間 （ET）15分遅れの株価
294.88M時価総額
損失額直近12ヶ月PER
詳細情報 Burning Rock Biotech Ltd 企業名
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Burning Rock Biotech Ltdの企業情報
企業コードBNR
会社名Burning Rock Biotech Ltd
上場日Jun 12, 2020
最高経営責任者「CEO」Han (Yusheng)
従業員数674
証券種類Depository Receipt
決算期末Jun 12
本社所在地No. 5 Xingdao Ring Road North
都市GUANGZHOU
証券取引所NASDAQ OMX - NASDAQ BASIC
国China
郵便番号510005
電話番号
ウェブサイトhttps://www.brbiotech.com/
企業コードBNR
上場日Jun 12, 2020
最高経営責任者「CEO」Han (Yusheng)
Burning Rock Biotech Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
Ms. Xiaozhi Hu
Ms. Xiaozhi Hu
Senior Director in Finance
Senior Director in Finance
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Yusheng Han
Mr. Yusheng Han
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Gang Lu
Mr. Gang Lu
Director
Director
--
--
Mr. Feng Deng
Mr. Feng Deng
Director
Director
--
--
Ms. Wendy Hayes, CPA
Ms. Wendy Hayes, CPA
Independent Director
Independent Director
--
--
Dr. Zhihong (Joe) Zhang, Ph.D.
Dr. Zhihong (Joe) Zhang, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Lisa (Licen) Xu
Dr. Lisa (Licen) Xu
Independent Director
Independent Director
--
--
収益内訳
FY2019
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
China (Mainland)
0.00
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Wed, Feb 4
更新時刻: Wed, Feb 4
株主統計
種類
株主統計
株主統計
比率
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
他の
57.55%
株主統計
株主統計
比率
Northern Light Venture Capital
11.68%
Kynam Capital Management LP
11.02%
Lyfe Capital
9.24%
CRCM L.P.
5.39%
China Merchants Bank Co Ltd
5.13%
他の
57.55%
種類
株主統計
比率
Private Equity
20.91%
Hedge Fund
11.37%
Investment Advisor/Hedge Fund
6.30%
Bank and Trust
5.14%
Corporation
3.92%
Investment Advisor
0.85%
Research Firm
0.58%
他の
50.93%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
39
4.08M
45.22%
-131.84K
2025Q3
49
4.65M
47.27%
-5.46K
2025Q2
58
4.65M
51.33%
-759.34K
2025Q1
65
5.41M
53.38%
+589.94K
2024Q4
74
5.54M
50.70%
+348.38K
2024Q3
93
5.26M
57.60%
-7.02K
2024Q2
108
5.27M
61.36%
-5.69K
2024Q1
121
5.30M
64.27%
-181.25K
2023Q4
137
5.23M
65.24%
+745.66K
2023Q3
205
5.00M
74.63%
-61.48K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Northern Light Venture Capital
1.05M
11.68%
--
--
Mar 31, 2025
Kynam Capital Management LP
994.88K
11.02%
--
--
Sep 30, 2025
Lyfe Capital
833.84K
9.24%
--
--
Mar 31, 2025
CRCM L.P.
486.43K
5.39%
+264.85K
+119.53%
Dec 16, 2025
China Merchants Bank Co Ltd
462.99K
5.13%
--
--
Mar 31, 2025
Quantum Boundary Holdings Ltd
353.92K
3.92%
+350.62K
+10637.83%
Mar 31, 2025
Amova Asset Management Americas, Inc
45.55K
0.5%
+45.55K
--
Dec 31, 2024
Amova Asset Management Co., Ltd.
34.84K
0.39%
-9.09K
-20.68%
Sep 30, 2025
Renaissance Technologies LLC
31.72K
0.35%
--
--
Sep 30, 2025
BofA Global Research (US)
29.18K
0.32%
-100.00
-0.34%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Avantis Responsible Emerging Markets Equity ETF
0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
Avantis Responsible Emerging Markets Equity ETF
比率0%
DFA Dimensional Emerging Markets Core Equity 2 ETF
比率0%
SPDR S&P Emerging Markets Small Cap ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
日付
配当落ち日
種類
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
